Latest Drugs, Latest Approval in Amylin analogs

What are Amylin analogs?

Amylin analogs are used in the treatment of diabetes. They are stable synthetic compounds, which are administered subcutaneously before meals, and work similarly to the physiological amylin.

Amylin is a 37 amino acid polypeptide hormone that is secreted with insulin from the beta cells in the pancreas. In diabetes, as less insulin is secreted there is also a deficiency of amylin. Amylin assists insulin in postprandial glucose control. It inhibits glucagon secretion, delays gastric emptying and signals satiety, suppressing the intake of food.